Cancer Risk

Showing 9-15 of 15 results

Research roundup: June 2023 edition

Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.

Research roundup: April 2023 edition

Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.

Research roundup: July 2021 edition

Usage of combined oral contraceptives to manage PMS and PMDD symptoms, surgical abortion pain management for patients with opioid use disorder, risks associated with post-placental IUD placement, and more.

Research roundup: June 2021 edition

In-clinic vs pharmacy provision of medication abortion, cost barriers to contraceptive access among community college students, opportunities for PrEP counseling for adolescent and young adults, and more.

Research roundup: August 2020 edition

The benefit of ultrasound guidance in IUD placement for patients with retroverted uteri, a demonstrated need for trauma-informed care in sexually-transmitted disease clinics, demand among abortion patients for more autonomous care options, and more.

Research roundup: September 2019 edition

An analysis of the efficacy and safety of telehealth medication abortion care, IUD use and a decreased risk of ovarian cancer, widespread support for HPV vaccination, and more.

What does evidence say about combined vs. progestin-only pills?

COCs or POPs? Here are some things to consider when helping a patient pick a pill.
  • Previous
  • 1
  • 2(current)
  • Next